GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Swiss National Bank

Swiss National Bank grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,290,087 shares of the company’s stock after buying an additional 2,900 shares during the quarter. Swiss National Bank’s holdings in GE HealthCare Technologies were worth $100,859,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of GEHC. Assetmark Inc. lifted its holdings in shares of GE HealthCare Technologies by 37.0% in the 3rd quarter. Assetmark Inc. now owns 2,697 shares of the company’s stock valued at $253,000 after buying an additional 729 shares during the period. Atria Investments Inc lifted its holdings in shares of GE HealthCare Technologies by 15.2% in the 3rd quarter. Atria Investments Inc now owns 11,833 shares of the company’s stock valued at $1,111,000 after buying an additional 1,565 shares during the period. Sigma Planning Corp lifted its holdings in shares of GE HealthCare Technologies by 5.9% in the 3rd quarter. Sigma Planning Corp now owns 5,950 shares of the company’s stock valued at $558,000 after buying an additional 330 shares during the period. Axxcess Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at about $207,000. Finally, Crossmark Global Holdings Inc. increased its stake in shares of GE HealthCare Technologies by 24.1% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 9,267 shares of the company’s stock valued at $870,000 after purchasing an additional 1,801 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $81.97 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The stock has a 50 day moving average of $87.26 and a two-hundred day moving average of $86.10. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The firm has a market cap of $37.48 billion, a P/E ratio of 18.93, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently weighed in on GEHC. Citigroup lifted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their price target for the company from $85.00 to $100.00 in a research note on Tuesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.